F. EKİNCİ Et Al. , "Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status," Eurasian Journal of Medical Investigation , vol.5, no.4, pp.500-507, 2021
EKİNCİ, F. Et Al. 2021. Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status. Eurasian Journal of Medical Investigation , vol.5, no.4 , 500-507.
EKİNCİ, F., ERDOĞAN, A. P., YILDIRIM, S., & ÖZVEREN, A., (2021). Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status. Eurasian Journal of Medical Investigation , vol.5, no.4, 500-507.
EKİNCİ, FERHAT Et Al. "Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status," Eurasian Journal of Medical Investigation , vol.5, no.4, 500-507, 2021
EKİNCİ, FERHAT Et Al. "Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status." Eurasian Journal of Medical Investigation , vol.5, no.4, pp.500-507, 2021
EKİNCİ, F. Et Al. (2021) . "Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status." Eurasian Journal of Medical Investigation , vol.5, no.4, pp.500-507.
@article{article, author={FERHAT EKİNCİ Et Al. }, title={Options in First Line Management of Metastatic Pancreatic Cancer and the Determinative Role of ECOG Performance Status}, journal={Eurasian Journal of Medical Investigation}, year=2021, pages={500-507} }